SKI Market

A+| A| A-|

Indian Indices

Sensex

76,264.33 736.38
( 0.97%)

Global Indices

Nasdaq

51,705.57 482.31
(0.94%)

Dow Jones

7,575.20 122.74
(1.65%)

Hang Seng

69,318.21 3,298.17
(5.00%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

539524

INE600L01024

147.5167422

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LALPATHLAB

51.06

27136.36

EPS(TTM)

Face Value()

Div & Yield %

31.7

1.51

Back

Suven Life Sciences reports consolidated net loss of Rs 101.92 crore in the December 2025 quarter

Jan 29,2026

Net Loss of Suven Life Sciences reported to Rs 101.92 crore in the quarter ended December 2025 as against net loss of Rs 39.12 crore during the previous quarter ended December 2024. Sales rose 74.53% to Rs 2.81 crore in the quarter ended December 2025 as against Rs 1.61 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.81	1.61	75
OPM %	-3677.94	-2435.40	-
PBDT	-100.58	-37.58	-168
PBT	-101.92	-39.12	-161
NP	-101.92	-39.12	-161

76,264.33 736.38 ( 0.97%)

51,705.57 482.31 (0.94%)

7,575.20 122.74 (1.65%)

69,318.21 3,298.17 (5.00%)

10,435.69 -36.03 (-0.34%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)